rs886037607
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_024782.3(NHEJ1):c.11dupT(p.Glu5fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,830 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
NHEJ1
NM_024782.3 frameshift
NM_024782.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.51
Genes affected
NHEJ1 (HGNC:25737): (non-homologous end joining factor 1) Double-strand breaks in DNA result from genotoxic stresses and are among the most damaging of DNA lesions. This gene encodes a DNA repair factor essential for the nonhomologous end-joining pathway, which preferentially mediates repair of double-stranded breaks. Mutations in this gene cause different kinds of severe combined immunodeficiency disorders. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.988 CDS is truncated, and there are 2 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-219158351-C-CA is Pathogenic according to our data. Variant chr2-219158351-C-CA is described in ClinVar as [Pathogenic]. Clinvar id is 985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHEJ1 | NM_024782.3 | c.11dupT | p.Glu5fs | frameshift_variant | 2/8 | ENST00000356853.10 | NP_079058.1 | |
NHEJ1 | NM_001377499.1 | c.11dupT | p.Glu5fs | frameshift_variant | 2/8 | NP_001364428.1 | ||
NHEJ1 | NM_001377498.1 | c.11dupT | p.Glu5fs | frameshift_variant | 2/8 | NP_001364427.1 | ||
NHEJ1 | NR_165304.1 | n.107dupT | non_coding_transcript_exon_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHEJ1 | ENST00000356853.10 | c.11dupT | p.Glu5fs | frameshift_variant | 2/8 | 1 | NM_024782.3 | ENSP00000349313.5 | ||
ENSG00000280537 | ENST00000318673.6 | n.*1133dupT | non_coding_transcript_exon_variant | 11/17 | 2 | ENSP00000320919.3 | ||||
ENSG00000280537 | ENST00000318673.6 | n.*1133dupT | 3_prime_UTR_variant | 11/17 | 2 | ENSP00000320919.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461830Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727218
GnomAD4 exome
AF:
AC:
2
AN:
1461830
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cernunnos-XLF deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 12, 2021 | For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with NHEJ1 deficiency related disease (PMID: 16439205). ClinVar contains an entry for this variant (Variation ID: 985). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu5Glyfs*43) in the NHEJ1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NHEJ1 are known to be pathogenic (PMID: 16439204, 20597108). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 19, 2006 | - - |
Severe combined immunodeficiency disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 15, 2024 | Variant summary: NHEJ1 c.11dupT (p.Glu5GlyfsX43) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251314 control chromosomes. c.11dupT has been reported in the literature in a homozygous individual affected with Severe Combined Immunodeficiency (Ahnesorg_2006). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in total loss of protein expression in cells from the individual (Ahnesorg_2006). The following publication have been ascertained in the context of this evaluation (PMID: 16439205). ClinVar contains an entry for this variant (Variation ID: 985). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at